|
2014
|
Invention
|
Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes,... |
|
|
Invention
|
Recombinant butyrylcholinesterases and truncates thereof. Isolated nucleic acids encoding polypep... |
|
2009
|
Invention
|
Anthrax vaccine formulation and uses thereof. An anthrax vaccine with alhydrogel as the adjuvant ... |
|
|
Invention
|
Anthrax vaccine formulation and uses thereof. An anthrax vaccine with alhydrogel as the adj... |
|
|
Invention
|
Stable vaccine compositions and methods of use. A stable lyophilized protein formulation containi... |
|
|
Invention
|
Stable vaccine compositions and methods of use. A stable lyophilized protein formulation co... |
|
|
Invention
|
Stable vaccine compositions and methods of use.
A stable lyophilized protein formulation contain... |
|
2008
|
P/S
|
Pharmaceutical preparations for counteracting the effects of biological and chemical warfare agen... |
|
2007
|
Invention
|
Non-human embryonic stem cell lines and transgenic animals derived from them. Stem cells and stem... |
|
|
Invention
|
Long half-life recombinant butyrylcholinesterase. The present invention provides for butyrylcholi... |
|
|
Invention
|
Method for assaying antigens.
A method for assaying an antigen adsorbed on a solid support is pr... |
|
2006
|
Invention
|
Production of hsa-linked butyrylcholinesterases in transgenic mammals.
The present invention pro... |
